Revolutionizing Drug Discovery: The Role of Artificial Intelligence and Machine
Learning

Abhishek      Verma; Ankit      Awasthi
Keywords: Drug discovery, artificial intelligence, machine learning, precision medicine, biomedical innovation, potential therapeutics.
[1]
Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P. Artificial intelligence to deep learning: Machine intelligence approach for drug discovery. Mol Divers  2021; 25(3): 1315-60.
 [http://dx.doi.org/10.1007/s11030-021-10217-3] [PMID:  33844136]

[2]
Vemula D, Jayasurya P, Sushmitha V, Kumar YN, Bhandari V. CADD, AI and ML in drug discovery: A comprehensive review. Eur J Pharm Sci  2023; 181: 106324.
 [http://dx.doi.org/10.1016/j.ejps.2022.106324] [PMID:  36347444]

[3]
Vatansever S, Schlessinger A, Wacker D, et al. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions. Med Res Rev  2021; 41(3): 1427-73.
 [http://dx.doi.org/10.1002/med.21764] [PMID:  33295676]

[4]
Alshehri FF. Integrated virtual screening, molecular modeling and machine learning approaches revealed potential natural inhibitors for epilepsy. Saudi Pharm J  2023; 31(12): 101835.
 [http://dx.doi.org/10.1016/j.jsps.2023.101835] [PMID:  37965486]

[5]
Tropsha A, Isayev O, Varnek A, Schneider G, Cherkasov A. Integrating QSAR modelling and deep learning in drug discovery: The emergence of deep QSAR. Nat Rev Drug Discov  2024; 23(2): 141-55.
 [PMID:  38066301]

[6]
Husnain A, Rasool S, Saeed A, Hussain HK. Revolutionizing pharmaceutical research: Harnessing machine learning for a paradigm shift in drug discovery. Int J Multidiscip Sci Arts  2023; 2(2): 149-57.
 [http://dx.doi.org/10.47709/ijmdsa.v2i2.2897]

[7]
Ayanoglu E, Davaslioglu K, Sagduyu YE. Machine learning in NextG networks via generative adversarial networks. IEEE Trans Cogn Commun Netw  2022; 8(2): 480-501.
 [http://dx.doi.org/10.1109/TCCN.2022.3153004]

[8]
Doherty T, Yao Z, Khleifat AA, et al. Artificial intelligence for dementia drug discovery and trials optimization. Alzheimers Dement  2023; 19(12): 5922-33.
 [http://dx.doi.org/10.1002/alz.13428] [PMID:  37587767]

[9]
Selvaraj G, Kaliamurthi S, Peslherbe GH, Wei DQ. Application of artificial intelligence in drug repurposing: A mini-review. Curr Chin Sci  2021; 1(3): 333-45.
 [http://dx.doi.org/10.2174/2210298101666210204162006]

[10]
Hoseini B, Jaafari MR, Golabpour A, Momtazi-Borojeni AA, Karimi M, Eslami S. Application of ensemble machine learning approach to assess the factors affecting size and polydispersity index of liposomal nanoparticles. Sci Rep  2023; 13(1): 18012.
 [http://dx.doi.org/10.1038/s41598-023-43689-4] [PMID:  37865639]

[11]
Hoseini B, Jaafari MR, Golabpour A, Momtazi-Borojeni AA, Eslami S. Optimizing nanoliposomal formulations: Assessing factors affecting entrapment efficiency of curcumin-loaded liposomes using machine learning. Int J Pharm  2023; 646: 123414.
 [http://dx.doi.org/10.1016/j.ijpharm.2023.123414] [PMID:  37714314]

[12]
Kaluarachchi T, Reis A, Nanayakkara S. A review of recent deep learning approaches in human-centered machine learning. Sensors  2021; 21(7): 2514.
 [http://dx.doi.org/10.3390/s21072514] [PMID:  33916850]

[13]
Alonso JM, Casalino G. Explainable artificial intelligence for human-centric data analysis in virtual learning environments. In: Higher Education Learning Methodologies and Technologies Online.  Springer 2019; pp. 125-38.
 [http://dx.doi.org/10.1007/978-3-030-31284-8_10]

[14]
Kulkov I. The role of artificial intelligence in business transformation: A case of pharmaceutical companies. Technol Soc  2021; 66: 101629.
 [http://dx.doi.org/10.1016/j.techsoc.2021.101629]

[15]
You Y, Lai X, Pan Y, et al. Artificial intelligence in cancer target identification and drug discovery. Signal Transduct Target Ther  2022; 7(1): 156.
 [http://dx.doi.org/10.1038/s41392-022-00994-0] [PMID:  35538061]

[16]
Katsila T, Spyroulias GA, Patrinos GP, Matsoukas MT. Computational approaches in target identification and drug discovery. Comput Struct Biotechnol J  2016; 14: 177-84.
 [http://dx.doi.org/10.1016/j.csbj.2016.04.004] [PMID:  27293534]

[17]
Sunil VS. The intersection of artificial intelligence and biological sciences 

[18]
Greene D, Hoffmann AL, Stark L. Better, nicer, clearer, fairer: A critical assessment of the movement for ethical artificial intelligence and machine learning. Hawaii International Conference on System Sciences Hawai, January.   2019; pp. 1-10.
 [http://dx.doi.org/10.24251/HICSS.2019.258]

[19]
Neethirajan S. Artificial Intelligence and Sensor Innovations: Enhancing Livestock Welfare with a Human-Centric Approach.  Human-Centric Intelligent Systems 2023; pp. 1-16.

[20]
Xu Y, Yao H, Lin K. An overview of neural networks for drug discovery and the inputs used. Expert Opin Drug Discov  2018; 13(12): 1091-102.
 [http://dx.doi.org/10.1080/17460441.2018.1547278] [PMID:  30449189]

[21]
Hafidi MM, Djezzar M, Hemam M, Amara FZ, Maimour M. Semantic web and machine learning techniques addressing semantic interoperability in Industry 4.0. Int J Web Inf Syst  2023; 19(3/4): 157-72.
 [http://dx.doi.org/10.1108/IJWIS-03-2023-0046]

[22]
Blanco-González A, Cabezón A, Seco-González A, et al. The role of ai in drug discovery: Challenges, opportunities, and strategies. Pharmaceuticals  2023; 16(6): 891.
 [http://dx.doi.org/10.3390/ph16060891] [PMID:  37375838]

[23]
Selvaraj C, Chandra I, Singh SK. Artificial intelligence and machine learning approaches for drug design: Challenges and opportunities for the pharmaceutical industries. Mol Divers  2022; 26(3): 1893-913.
 [http://dx.doi.org/10.1007/s11030-021-10326-z] [PMID:  34686947]

[24]
Tiwari PC, Pal R, Chaudhary MJ, Nath R. Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges. Drug Dev Res  2023; 84(8): 1652-63.
 [http://dx.doi.org/10.1002/ddr.22115] [PMID:  37712494]
Cite As
Current Pharmaceutical Design

Revolutionizing Drug Discovery: The Role of Artificial Intelligence and Machine Learning
